NasdaqGS - Delayed Quote USD

Editas Medicine, Inc. (EDIT)

5.49 -0.06 (-1.08%)
At close: April 19 at 4:00 PM EDT
5.60 +0.11 (+2.01%)
After hours: April 19 at 7:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
78,123.00
78,123.00
19,712.00
25,544.00
90,732.00
Operating Expense
247,304.00
247,304.00
245,662.00
218,690.00
225,572.00
Operating Income
-169,181.00
-169,181.00
-225,950.00
-193,146.00
-134,840.00
Net Non Operating Interest Income Expense
17,566.00
17,566.00
5,518.00
607.00
2,605.00
Other Income Expense
-1,604.00
-1,604.00
1,293.00
37.00
16,259.00
Pretax Income
-153,219.00
-153,219.00
-220,432.00
-192,502.00
-115,976.00
Net Income Common Stockholders
-153,219.00
-153,219.00
-220,432.00
-192,502.00
-115,976.00
Diluted NI Available to Com Stockholders
-153,219.00
-153,219.00
-220,432.00
-192,502.00
-115,976.00
Basic EPS
-2.69
-2.02
-3.21
-2.85
-1.98
Diluted EPS
-2.69
-2.02
-3.21
-2.85
-1.98
Basic Average Shares
72,720.88
75,965.63
68,664.82
67,619.39
58,609.39
Diluted Average Shares
72,720.88
75,965.63
68,664.82
67,619.39
58,609.39
Total Operating Income as Reported
-169,181.00
-169,181.00
-225,950.00
-193,146.00
-134,840.00
Total Expenses
247,304.00
247,304.00
245,662.00
218,690.00
225,572.00
Net Income from Continuing & Discontinued Operation
-153,219.00
-153,219.00
-220,432.00
-192,502.00
-115,976.00
Normalized Income
-153,219.00
-153,219.00
-220,432.00
-192,502.00
-115,976.00
Interest Income
17,566.00
17,566.00
5,518.00
607.00
2,605.00
Net Interest Income
17,566.00
17,566.00
5,518.00
607.00
2,605.00
EBIT
-169,181.00
-169,181.00
-225,950.00
-193,146.00
-134,840.00
EBITDA
-163,117.00
-163,117.00
-219,613.00
-188,093.00
-130,881.00
Reconciled Depreciation
6,064.00
6,064.00
6,337.00
5,053.00
3,959.00
Net Income from Continuing Operation Net Minority Interest
-153,219.00
-153,219.00
-220,432.00
-192,502.00
-115,976.00
Normalized EBITDA
-163,117.00
-163,117.00
-219,613.00
-188,093.00
-130,881.00
12/31/2020 - 2/3/2016
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

NTLA Intellia Therapeutics, Inc.
21.57
+1.17%
 
BEAM Beam Therapeutics Inc.
23.90
-1.69%
 
CRSP CRISPR Therapeutics AG
55.05
-1.98%
 
VERV Verve Therapeutics, Inc.
6.64
-0.30%
 
CRBU Caribou Biosciences, Inc.
3.8500
-1.53%
 
BLUE bluebird bio, Inc.
1.0200
+7.03%
 
ADPT Adaptive Biotechnologies Corporation
2.4000
+2.78%
 
DTIL Precision BioSciences, Inc.
9.74
-9.14%
 
RXRX Recursion Pharmaceuticals, Inc.
7.35
-0.68%
 
SAGE Sage Therapeutics, Inc.
13.33
+2.26%